Bausch + Lomb Announces Participation at the RBC Capital Markets Global Healthcare Conference
Rhea-AI Summary
Bausch + Lomb (NYSE/TSX: BLCO) announced that CEO Joseph C. Papa will speak at the RBC Capital Markets Global Healthcare Conference on May 17, 2022, at 9:30 a.m. ET. A live webcast will be accessible on the company's Investor Relations page. Bausch + Lomb is a prominent global eye health company founded in 1853, focusing on a diverse portfolio of over 400 products, including contact lenses and surgical instruments, with operations in nearly 100 countries.
Positive
- CEO Joseph C. Papa's participation in the RBC Capital Markets Global Healthcare Conference may enhance visibility and investor interest.
- The company has a comprehensive product portfolio with over 400 offerings, indicating strong market presence.
Negative
- None.
News Market Reaction – BLCO
In the trading session that priced this news, BLCO gained 1.43%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
VAUGHAN, ON, May 13, 2022 /PRNewswire/ -- Bausch + Lomb Corporation, (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to participate at the RBC Capital Markets Global Healthcare Conference on May 17, 2022, at 9:30 a.m. ET.
A live webcast and audio archive of the conferences will be available on the Investor Relations page of the Bausch + Lomb website at: https://ir.bausch.com/investors/events-presentations.
About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.
Investor Contact: | Media Contact: |
Arthur Shannon | Lainie Keller |
(908) 927-1198 | |
Allison Ryan | Kristy Marks |
(877) 354-3705 (toll free) | (908) 927-0683 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch--lomb--announces-participation-at-the-rbc-capital-markets-global-healthcare-conference-301546237.html
SOURCE Bausch + Lomb Corporation